ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
62,799.96
-0.14%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Clearmind Medicine Inc (CMND)

  7. Clearmind Medicine Inc (CMND) Noticias

CMND Clearmind Medicine Inc

1.14
-0.0301 (-2.57%)
03 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Clearmind Medicine Inc CMND NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.0301 -2.57% 1.14 18:32:01
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
1.20 1.15 1.23 1.19 1.1701
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202415:15GLOBEClearmind Applies to Cease Being a Reporting Issuer in..
17/4/202406:49GLOBEClearmind Medicine Announces Exclusive Licensing Agreement..
10/4/202406:17GLOBEClearmind Medicine Files U.S. Patent Application for..
09/4/202407:07GLOBEClearmind Medicine CEO Issues Letter to Shareholders
19/3/202406:55GLOBEBreakthrough in Wellness: Clearmind Medicine's Psychedelic..
13/3/202407:14GLOBEClearmind Medicine Obtains Clearance for its Psychedelic-..
13/3/202406:30GLOBEClearmind Medicine Received Approval for a Voluntary..
27/2/202406:58GLOBESciSparc-Clearmind Partnership Yields Three New..
23/2/202406:06GLOBEClearmind Medicine Receives Approval to Commence its Phase..
20/2/202406:14GLOBESciSparc and Clearmind Continue to Strengthen International..
05/2/202406:51GLOBEClearmind Medicine Receives Patent Approval for its..
01/2/202407:15GLOBEClearmind Medicine Announces Exclusive, Long-Term Licensing..
16/1/202410:19GLOBEClearmind Medicine Inc. Closes US$2.4 Million Registered..
11/1/202408:28GLOBEClearmind Medicine Inc. Announces Pricing of $2.4 Million..
10/1/202406:18GLOBEClearmind Medicine Completed Type A Meeting with the FDA
04/1/202406:18GLOBEClearmind Medicine and SciSparc Reflect on Successful..
14/12/202307:26GLOBEClearmind Medicine Announces It Is In Compliance with All..
05/12/202307:47GLOBEClearmind Medicine Achieved Positive Results in Cocaine..
01/12/202307:14GLOBEWeight loss MEAI: Clearmind Medicine’s Novel Obesity Drug..
28/11/202307:25GLOBEClearmind Medicine Announces Positive Results from its..
27/11/202307:55GLOBEClearmind Medicine to Participate in Traditional vs. Novel..
21/11/202307:15GLOBEClearmind Medicine Announces 1-for-30 Reverse Share Split
17/11/202315:15GLOBEClearmind Medicine Announces Receipt of Nasdaq Delisting..
15/11/202306:37GLOBEClearmind Medicine Announces Shareholders Meeting Results
09/11/202308:20GLOBEClearmind Medicine to Pioneer Psychedelic Clinical Trials..
05/10/202308:00GLOBEClearmind Medicine to Present at the 8th Annual Dawson James..
21/9/202308:35GLOBEDawson James Securities Announces October Date for 8th..
18/9/202311:16GLOBEClearmind Medicine Closes US$2.25 Million Public Offering
14/9/202308:23GLOBEClearmind Medicine Announces Pricing of US$2.25 Million..
06/9/202308:20GLOBEClearmind Medicine Announces Clinical Research Collaboration..
14/8/202307:25GLOBEClearmind Medicine Announces Collaboration with CTS Ltd., a..
01/8/202308:00GLOBESciSparc and Clearmind Collaboration Continues to Increase..
17/7/202315:15GLOBEClearmind Medicine Announces Share-Based Payment for the..
11/7/202307:30GLOBEDr. Fatima Cody Stanford, Associate Professor of Medicine..
16/6/202308:05GLOBEClearmind Medicine and SciSparc to Conduct Study Evaluating..
09/6/202308:30GLOBEClearmind Medicine to Host Virtual Investor Conference on..
22/5/202307:30GLOBEClearmind Medicine Announces First US Site for its Phase..
19/5/202315:15GLOBEClearmind Medicine Announces Receipt of Nasdaq Minimum Bid..
17/5/202308:00GLOBEClearmind Medicine to Host Virtual Investor Conference on..
12/5/202308:00GLOBEClearmind Medicine Announces IRB Approval to Conduct..
09/5/202315:15GLOBEClearmind Medicine Retains Crescendo Communications LLC. for..
08/5/202307:30GLOBEClearmind Medicine Strengthens Scientific Advisory Board..

Su Consulta Reciente

NASDAQ
CMND
Clearmind Medicine
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados